It is interesting to note that, in two independent studies, the therapeutic effect of intramuscular-injected IDO shRNA and bacteria-transformed IDO shRNA was eradicated when tumor-bearing mice received a neutrophil-depleting antibody [78,79]. The gene discussed is IDO1; the disease is neoplasm.